EP2508201A4 - Procédé d'identification d'animaux vaccinés contre brucella - Google Patents

Procédé d'identification d'animaux vaccinés contre brucella

Info

Publication number
EP2508201A4
EP2508201A4 EP10834263.5A EP10834263A EP2508201A4 EP 2508201 A4 EP2508201 A4 EP 2508201A4 EP 10834263 A EP10834263 A EP 10834263A EP 2508201 A4 EP2508201 A4 EP 2508201A4
Authority
EP
European Patent Office
Prior art keywords
identification
animals vaccinated
vaccinated against
against brucella
mammals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10834263.5A
Other languages
German (de)
English (en)
Other versions
EP2508201A1 (fr
Inventor
Dolset Maria Grillo
Zabalza Beatriz Amorena
Andres Cara Damian De
Robles Edgardo Moreno
Olarte Esteban Chaves
Verri Caterina Guzman
Diaz Carlos Chacon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIVERSIDAD NACIONALDE COSTA RICA (UNA)
Universidad de Costa Rica
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Universidad de Costa Rica
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Publica de Navarra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Costa Rica, Consejo Superior de Investigaciones Cientificas CSIC, Universidad Publica de Navarra filed Critical Universidad de Costa Rica
Publication of EP2508201A1 publication Critical patent/EP2508201A1/fr
Publication of EP2508201A4 publication Critical patent/EP2508201A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/098—Brucella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/23—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Brucella (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP10834263.5A 2009-12-03 2010-11-29 Procédé d'identification d'animaux vaccinés contre brucella Withdrawn EP2508201A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200931101A ES2372187B8 (es) 2009-12-03 2009-12-03 Procedimiento de identificación de animales vacunados frente a brucella.
PCT/ES2010/070784 WO2011067446A1 (fr) 2009-12-03 2010-11-29 Procédé d'identification d'animaux vaccinés contre brucella

Publications (2)

Publication Number Publication Date
EP2508201A1 EP2508201A1 (fr) 2012-10-10
EP2508201A4 true EP2508201A4 (fr) 2013-08-07

Family

ID=44114638

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10834263.5A Withdrawn EP2508201A4 (fr) 2009-12-03 2010-11-29 Procédé d'identification d'animaux vaccinés contre brucella

Country Status (7)

Country Link
EP (1) EP2508201A4 (fr)
CN (1) CN102781468A (fr)
CR (1) CR20120301A (fr)
ES (1) ES2372187B8 (fr)
MX (1) MX2012006303A (fr)
PE (1) PE20121648A1 (fr)
WO (1) WO2011067446A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3713598A1 (fr) 2017-11-24 2020-09-30 Consejo Superior de Investigaciones Cientificas (CSIC) <smallcaps/> brucella souche vaccinale modifi& xc9;e depour le traitement de la brucellose
CN110863031A (zh) * 2019-09-29 2020-03-06 安徽医科大学第一附属医院 一种检测布鲁菌病治疗效果的标志物及其应用
CN111796091B (zh) * 2020-07-20 2023-09-08 天康生物制药有限公司 用于区分动物感染布氏杆菌或布氏杆菌菌影疫苗的试剂盒
WO2022271201A2 (fr) * 2021-01-07 2022-12-29 International Advantage, Inc. Expression des gènes ace2 et tmprss2 en tant que marqueurs prédictifs de la gravité de la covid-19

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054508A2 (fr) * 2002-12-12 2004-07-01 Walter Reed Army Institute Of Research Department Of The Army Compositions immunogeniques comprenant des souches hotes de phenotypes rugueux de brucella et fragments d'adn de complementation
CN101586120A (zh) * 2009-07-15 2009-11-25 中国农业科学院哈尔滨兽医研究所 狂犬病病毒Flury-LEP疫苗株反向遗传操作系统及LEP绿色荧光蛋白重组病毒载体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101240290B (zh) * 2008-02-29 2011-06-15 杭州师范大学 一种含绿色荧光蛋白基因的植物转基因表达载体及其构建方法和应用
US20100226942A1 (en) * 2008-10-30 2010-09-09 Schurig Gerhardt G Producing an immune response for reducing the risk of developing brucellosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004054508A2 (fr) * 2002-12-12 2004-07-01 Walter Reed Army Institute Of Research Department Of The Army Compositions immunogeniques comprenant des souches hotes de phenotypes rugueux de brucella et fragments d'adn de complementation
CN101586120A (zh) * 2009-07-15 2009-11-25 中国农业科学院哈尔滨兽医研究所 狂犬病病毒Flury-LEP疫苗株反向遗传操作系统及LEP绿色荧光蛋白重组病毒载体

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HARMS JEROME S ET AL: "Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella", JOURNAL OF IMMUNE BASED THERAPIES AND VACCINES, BIOMED CENTRAL LTD., LONDON, GB, vol. 7, no. 1, 6 January 2009 (2009-01-06), pages 1, XP021050250, ISSN: 1476-8518, DOI: 10.1186/1476-8518-7-1 *
KARINA A PASQUEVICH ET AL: "Immunization with recombinant Brucella species outer membrane protein Ompl6 or Ompl9 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucedda abortus infection", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MACROBIOLOGY, USA, vol. 77, no. 1, 1 January 2009 (2009-01-01), pages 436 - 445, XP008156270, ISSN: 0019-9567, DOI: 10.1128/IAI.01151-08 *
PARTHIBAN RAJASEKARAN ET AL: "Brucella abortus Strain RB51 Leucine Auxotroph as an Environmentally Safe Vaccine for Plasmid Maintenance and Antigen Overexpression", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 74, no. 22, 15 November 2008 (2008-11-15), pages 7051 - 7055, XP008153314, ISSN: 0099-2240, [retrieved on 20081003], DOI: 10.1128/AEM.01511-08 *
See also references of WO2011067446A1 *
STEPHAN KÖHLER ET AL: "Constitutive and Inducible Expression of Green Fluorescent Protein in Brucella suis", vol. 67, no. 12, 1 December 1999 (1999-12-01), pages 6695 - 6697, XP008153302, ISSN: 0019-9567, Retrieved from the Internet <URL:http://iai.asm.org/content/67/12/6695.abstract> *

Also Published As

Publication number Publication date
MX2012006303A (es) 2012-09-07
EP2508201A1 (fr) 2012-10-10
CN102781468A (zh) 2012-11-14
ES2372187B8 (es) 2013-04-29
CR20120301A (es) 2013-02-27
PE20121648A1 (es) 2012-12-24
WO2011067446A1 (fr) 2011-06-09
ES2372187B1 (es) 2012-11-26
ES2372187A1 (es) 2012-01-17

Similar Documents

Publication Publication Date Title
IL274871A (en) Proteins that bind to human 23–IL antigen
CO6362024A2 (es) Anticuerpos humanos de alta afinidad para el receptor il-4 humano
CY1115091T1 (el) Διειδικες πρωτεϊνες προσδεσης αντιγονων
GB201009273D0 (en) Novel vaccine
IN2012DN02368A (fr)
MX2012007340A (es) Anticuerpos anti/her3 y usos de los mismos.
NZ595707A (en) Cancer antigen helper peptide
CL2013001124A1 (es) Anticuerpo aislado o una proteína que comprende una porción de enlace de antígeno de un anticuerpo dirigido contra un polipéptido de cd40; composicion farmacéutica que comprende dicho anticuerpo; ácido nucleico que codifica el anticuerpo; vector de clonación; proceso de producción del anticuerpo.
TR201908635T4 (tr) Protein kodlayıcı rna?nın lipozomal verilmesine uygun lipitler.
EP2508201A4 (fr) Procédé d&#39;identification d&#39;animaux vaccinés contre brucella
WO2013043933A3 (fr) Protéines de liaison à un antigène cd27l
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
BR112014020019A2 (pt) vetores poxvirais recombinantes expressando tanto proteínas da raiva e ox40 e vacinas feitos a partir destes
WO2014005683A8 (fr) Vaccin à adn, destiné à être utilisé chez des patients atteints de cancer du pancréas
CL2012003094A1 (es) Anticuerpo bivalente aislado o fragmento bivalente del mismo, que actua sobre lrp6 potenciando una señal wnt al agrupar uno o mas receptores lrp6 en presencia de una proteina de union de lrp6; acido nucleico que lo codifica; vector que comprende dicho acido nucleico; composicion farmaceutica que comprende un anticuerpo multivalente anti-lrp6; y su uso para tratar cancer.
GB201000588D0 (en) Bacterial host strain
IN2009CN03372A (fr)
CA2763359C (fr) Nouvelles souches de rotavirus humain et nouveaux vaccins
WO2013084071A3 (fr) Vaccin à base de toxines de clostridium difficile
BR112016009460A8 (pt) método para detectar a presença de anticorpos neutralizantes, e, kit
EP2559762A4 (fr) Nouvel anticorps monoclonal anti-hsp90
EP2478363A4 (fr) Identification de proteines discriminantes par profilage d&#39;anticorps, procedes et appareil d&#39;identification d&#39;un individu
BR112013004594A2 (pt) método para a determinação de um conteúdo de antígeno
NZ596501A (en) Casb7439 constructs
CY1125328T1 (el) Ανασυνδυασμενο εμβολιο ιου λευχαιμιας αιλουροειδων περιεχοντας βελτιστοποιημενο γονιδιο φακελου ιου λευχαιμιας αιλουροειδων

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120629

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20130705

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/10 20060101AFI20130701BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: UNIVERSIDAD DE COSTA RICA (UCR)

Owner name: UNIVERSIDAD NACIONALDE COSTA RICA (UNA)

Owner name: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (C

17Q First examination report despatched

Effective date: 20150217

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20171114